BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9797844)

  • 1. Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression.
    Ueta Y; Levy A; Powell MP; Lightman SL; Kinoshita Y; Yokota A; Shibuya I; Yamashita H
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):29-38. PubMed ID: 9797844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing hormone transcripts in human pituitary adenomas.
    Levy A; Lightman SL
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1474-6. PubMed ID: 1350590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system.
    Matsuno A; Katakami H; Nagashima T; Teramoto A; Osamura RY; Kirino T
    Hum Pathol; 2000 Jul; 31(7):789-94. PubMed ID: 10923914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.
    Lopes MB; Gaylinn BD; Thorner MO; Stoler MH
    Am J Pathol; 1997 Jun; 150(6):1885-91. PubMed ID: 9176381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
    Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol phospholipid turnover and intracellular Ca2+ responses to thyrotrophin-releasing hormone, gonadotrophin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas.
    Levy A; Lightman SL; Hoyland J; Mason WT
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):73-9. PubMed ID: 2169360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutations in pituitary adenomas: rare events.
    Levy A; Hall L; Yeudall WA; Lightman SL
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
    Thapar K; Kovacs K; Stefaneanu L; Scheithauer B; Killinger DW; Lioyd RV; Smyth HS; Barr A; Thorner MO; Gaylinn B; Laws ER
    Am J Pathol; 1997 Sep; 151(3):769-84. PubMed ID: 9284826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular calcium ion responses to somatostatin in cells from human somatotroph adenomas.
    Chen ZP; Xu S; Lightman SL; Hall L; Levy A
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):45-53. PubMed ID: 9059557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas.
    Ueta Y; Levy A; Chowdrey HS; Lightman SL
    J Neuroendocrinol; 1995 Jun; 7(6):467-74. PubMed ID: 7550294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of growth hormone (GH)-releasing hormone by GH-producing pituitary adenoma assessed by cell immunoblot analysis.
    Kawamoto K; Uozumi T; Arita K; Takechi A; Kawamoto H
    Endocr J; 1995 Feb; 42(1):89-93. PubMed ID: 7599704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas.
    Salvatori R; Thakker RV; Lopes MB; Fan X; Eswara JR; Ellison D; Lees P; Harding B; Yang I; Levine MA
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):301-7. PubMed ID: 11298081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.